Abiopharma

🔍 Kenneth Nadav (Director)

Company: InMode Ltd. (INMD)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 2,000 shares of Ordinary Shares (Direct)
  Date: 2026-07-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents ordinary shares of InMode Ltd. (the "Company") underlying restricted stock units ("RSUs") granted on July 30, 2026 in a transaction that was exempt under Rule 16b-3. Each RSU represents the contingent right to receive one ordinary share of the Company.
• F2: The total reported in Column 5 includes (i) 2,000 newly-awarded RSUs, (ii) 1,500 unvested RSUs previously reported in Table II, and (iii) 1,500 of the Company's ordinary shares.